Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This is a phase 1b study, which means that the purpose of the study is to establish the maximum dose of a pill drug called BYL719, when given with a standard treatment for patients with head and neck squamous cell cancer.
Critère d'inclusion
- Head and Neck Squamous Cell Cancer